Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_assertion type Assertion NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_head.
- NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_assertion description "[IL-4 protein levels were 20-fold higher in patients with painless neuropathy (p < 0.0001) and 17-fold higher in patients with painful neuropathy (p < 0.0001) than in healthy control subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_provenance.
- NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_assertion evidence source_evidence_literature NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_provenance.
- NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_assertion SIO_000772 17606879 NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_provenance.
- NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_assertion wasDerivedFrom befree-20150227 NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_provenance.
- NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_assertion wasGeneratedBy ECO_0000203 NP495809.RAj2X7JR-hoOTFK1z6UtwXaE5-Wsj-hqyV0quL6m-OpeA130_provenance.